SynVent is Syngene’s platform for fully integrated therapeutic discovery and development across large and small molecules.
Emerging biopharma work at the forefront of science, often venturing into disease areas where little or no real-world data exists to work with or regulatory frameworks to work within.
Our Dedicated Centers offer dedicated multi-disciplinary scientific teams, support personnel, and a tailormade ring-fenced and fire-walled infrastructure as per client specifications to support their R&D goals
Centre for Advanced Protein Studies [CAPS] is a state-of-the-art advanced national facility located in the Syngene campus, Bangalore.
Choose from a variety of resources to get a better understanding of Syngene’s point of view, expertise or approach to drug discovery, development and manufacturing to ensure client success.
Syngene’s offers an end-to-end platform to deliver integrated and standalone services for small molecules across the Development continuum.
Syngene offers integrated and standalone services across the drug discovery continuum from Target Identification to IND enabling.
Syngene offers biologics development and manufacturing solutions across mammalian and microbial systems.
Syngene offers integrated and standalone services across the drug discovery continuum from Target Identification to IND enabling.
Syngene’s offers an end-to-end platform to deliver integrated and standalone services for small molecules across the Development continuum.
Syngene offers biologics development and manufacturing solutions across mammalian and microbial systems.
Syngene offers end-to-end and integrated solutions for PROTACs ranging from early proof-of-concept studies to identifying a development candidate.
Syngene’s Target Identification and Validation services combine data, informatics, and knowledge about biological target assays for holistic target assessment and risk mitigation in drug discovery.
Syngene, with its comprehensive suite of DMPK profiling assays, can help you achieve a high rate of success with your clinical candidates across drug modalities.
Syngene’s Chemistry process research lab acts as a bridge between drug discovery and development when faster delivery of chemical compounds is required – mg to kg.
Syngene has full value-chain Process Research and Development (PRD) capabilities for NCEs and advanced intermediates.
Syngene supports both developmentand manufacturing of Drug Products from early to late stage
© 2023. Syngene International Limited
We use cookies to improve your experience on our site and show you information relevant to your requirements.
To find out more, read our Privacy Policy and Cookies Policy.